Top news of the week: 22.11.2022.
This Biotech Company’s Goal Is To Have A Plant-Based American Flag Fly Over The White House
Read the story to find out how the U.S. government can help strengthen backing for bio-based products through their BioPreferred program and federal loan guarantees.
Can A Desktop DNA Printer Stomp Out The Next Pandemic?
Telesis Bio wants to bring the ability to write DNA to every lab with their desktop automated gene synthesis platform, Digital-to-biological converter™
Startup Cradle Lets You Design Custom Proteins By Just Typing In A Prompt
There is a new company on the block whose mission is to make programming biology easy. The European startup called Cradle is emerging from stealth after building out their platform.
Friend-Shoring Trend Trickles to Biopharma Manufacturing
U.S. biomanufacturers are near-shoring or “friend-shoring” to regions that are friendly to U.S. policy or, minimally, are exempt from zealous COVID-19 restrictions.
A former Harvard chemist just raised $178 million for a biotech startup that plans to treat previously untreatable cancers
FogPharma is now on the cusp of starting human testing for a game-changing cancer drug, CEO Greg Verdine told Insider.
Biotechs reveal layoffs, research revamps in third quarter earnings
Tricida, Harpoon, Freeline and three other small drug developers have this week announced plans to cut staff or to reprioritize their drug development.
MassBio and Beacon Capital Partners are launching a life sciences workforce training center to meet growing demand
DORCHESTER, MA—November 21, 2022—Today, the Massachusetts Biotechnology Council (MassBio®) and Beacon Capital Partners announced a partnership to launch a nearly 4,000 square foot workforce ...
This Biotech Entrepreneur Just Raised $10 Million To Develop A Universal Flu Vaccine
Distributed Bio cofounder Jacob Glanville’s new venture, Centivax, just raised a seed round to lay a foundation for human trials of its promising vaccine platform.